MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, ORMP has $220,493K in assets. $52,179K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
2224.50%
Cash Ratio
852.74%
Assets Breakdown
    • Investments at fair value
    • Investment in associate at fair ...
    • Cash and cash equivalents
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Deferred tax liabilities
    • Others

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Balance Sheets
2025-09-30
2025-06-30
Cash and cash equivalents
52,179 15,797
Short-term deposits
4,038 22,865
Marketable securities
4,956 1,753
Investments at fair value
73,514 57,525
Prepaid expenses and other current assets
1,430 1,086
Total current assets
136,117 99,026
Long-term deposits
2 2
Investments at fair value
11,410 8,789
Investment in associate at fair value
64,803 44,298
Loan to an equity method investee
1,044 2,529
Investment in real estate
2,122 1,951
Other non-marketable equity securities
3,524 3,524
Amounts funded in respect of employee rights upon retirement
40 38
Property and equipment, net
614 645
Operating lease right-of-use assets
817 882
Total long-term assets
84,376 62,658
Total assets
220,493 161,684
Accounts payable and accrued expenses
4,861 2,159
Payable to related parties
1 34
Deferred income
986 1,236
Operating lease liabilities
271 264
Total current liabilities
6,119 3,693
Long-term deferred revenues
2,000 2,000
Long-term deferred income
1,496 1,724
Other liabilities
-0
Employee rights upon retirement
38 36
Operating lease liabilities
589 648
Deferred tax liabilities
7,921 -
Total long-term liabilities
12,044 4,408
Common stock, 0.012 par value (60,000,000 authorized shares 40,838,226 and 39,919,545 shares issued and outstanding as of september 30, 2025 and december 31, 2024, respectively)
490 491
Additional paid-in capital
325,367 325,008
Accumulated deficit
-122,575 -170,970
Total stockholders equity
203,282 154,529
Non-controlling interests
-952 -946
Total equity
202,330 153,583
Total liabilities and equity
220,493 161,684
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Operating leaseright-of-use assets$817K Property and equipment,net$614K Amounts funded inrespect of employee...$40K Other non-marketableequity securities$3,524K Investment in real estate$2,122K Loan to an equitymethod investee$1,044K Investment in associate atfair value$64,803K Investments at fair value$11,410K Long-term deposits$2K Prepaid expenses andother current assets$1,430K Investments at fair value$73,514K Marketable securities$4,956K Short-term deposits$4,038K Cash and cashequivalents$52,179K Total long-termassets$84,376K Total current assets$136,117K Total assets$220,493K Total liabilities andequity$220,493K Total equity$202,330K Total long-termliabilities$12,044K Total currentliabilities$6,119K Non-controlling interests-$952K Total stockholdersequity$203,282K Deferred tax liabilities$7,921K Operating leaseliabilities$589K Employee rights uponretirement$38K Long-term deferred income$1,496K Long-term deferredrevenues$2,000K Operating leaseliabilities$271K Deferred income$986K Payable to relatedparties$1K Accounts payable andaccrued expenses$4,861K Accumulated deficit-$122,575K Additional paid-in capital$325,367K Common stock, 0.012 parvalue (60,000,000...$490K

ORAMED PHARMACEUTICALS INC. (ORMP)

ORAMED PHARMACEUTICALS INC. (ORMP)